Cargando…
Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
Autores principales: | Kubuki, Yoko, Shide, Kotaro, Kameda, Takuro, Yamaji, Takumi, Sekine, Masaaki, Kamiunten, Ayako, Akizuki, Keiichi, Shimoda, Haruko, Tahira, Yuki, Nakamura, Kenichi, Abe, Hiroo, Miike, Tadashi, Iwakiri, Hisayoshi, Tahara, Yoshihiro, Sueta, Mitsue, Hashimoto, Kanna, Yamamoto, Shojiro, Hasuike, Satoru, Hidaka, Tomonori, Nagata, Kenji, Kitanaka, Akira, Shimoda, Kazuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203995/ https://www.ncbi.nlm.nih.gov/pubmed/28029004 http://dx.doi.org/10.3343/alm.2017.37.2.159 |
Ejemplares similares
-
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
por: Shide, Kotaro, et al.
Publicado: (2019) -
Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib
por: Shide, K, et al.
Publicado: (2017) -
Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
por: Ozono, Yoshinori, et al.
Publicado: (2020) -
Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms
por: Kameda, Takuro, et al.
Publicado: (2015) -
Outcome of allogeneic hematopoietic cell transplantation in patients with adult T‐cell leukemia
por: Kamiunten, Ayako, et al.
Publicado: (2018)